News - Sanofi

Filter

Current filters:

Sanofi

Popular Filters

170 to 194 of 311 results

FDA advisory panel votes 9 to 6 to approve Genzyme's Kynamro

19-10-2012

The US Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory yesterday voted by…

BiotechnologyCardio-vascularGenzymeIsis PharmaceuticalsKynamroNorth AmericaPharmaceuticalRare diseasesRegulationSanofi

US FDA agrees to review Sanofi Pasteur's new quadrivalent influenza vaccine

18-10-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) says it has filed a supplemental Biologics…

Anti-viralsNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Highlights from ECTRIMS include new data for Gilenya, Sativex and Aubagio

14-10-2012

New data presented at the 28th congress of the European Committee for Treatment and Research in Multiple…

AlmirallAubagioBiotechnologyGenzymeGilenyaGW PharmaceuticalsNeurologicalNovartisPharmaceuticalResearchSanofiSativex

Watson gets FDA approval for generic Sanctura XR and Avapro

14-10-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug…

AllerganAvaproCardio-vascularGenericsGenito-urinaryNorth AmericaRegulationSanctura XRSanofiWatson Pharmaceuticals

Positive Ph III VELOUR results with Sanofi's Zaltrap

10-10-2012

French drug major Sanofi (Euronext: SAN) says that positive detailed results from the pivotal Phase III…

OncologyPharmaceuticalRegeneronResearchSanofiZaltrap

Sanofi links with Massachusetts General Hospital for oncology research

09-10-2012

French drug major Sanofi (Euronext: SAN) has entered in to a two-year agreement with Massachusetts General…

OncologyPharmaceuticalResearchSanofi

News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma

02-10-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) saw its shares dip 1.8% to £29.02 in early afternoon…

AstraZenecaFinancialManagementOctapharmaPharmaceuticalResearchSanofi

Osiris regains worldwide rights to Prochymal and Chondrogen from Sanofi

30-09-2012

As a result of the termination of its collaboration with Genzyme, a subsidiary of French drug major Sanofi…

BiotechnologyChondrogenGenzymeImmunologicalsInflammatory diseasesLicensingOsiris TherapeuticsPharmaceuticalProchymalSanofi

Sanofi to cut 900 French research posts, a lot fewer than had been feared

25-09-2012

French drug major Sanofi (Euronext: SAN) yesterday fleshed out on its plans for changes in its research…

BiotechnologyEuropeManagementPharmaceuticalResearchSanofi

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam

20-09-2012

Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Oncodesign in up to 130 million-euro deal with Sanofi

14-09-2012

Oncodesign, a Dijon, France-based drug discovery company and oncology pharmacology service provider,…

LicensingOncodesignOncologyPharmaceuticalResearchSanofi

FDA thumbs up for Sanofi's MS drug Aubagio

13-09-2012

As has been largely expected, the US Food and Drug Administration yesterday approved marketing of French…

AubagioBiotechnologyGenzymeNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur

12-09-2012

The Dengue Vaccine Initiative (DVI) has welcomed new clinical trial results that reveal progress in developing…

CYD-TDVSanofiSanofi Pasteur

Impax Labs settles with Genzyme over Renvela and Renagel generics

05-09-2012

USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi's…

GenzymeImpax LaboratoriesPatentsPharmaceuticalRenagelRenvelaSanofi

New Zealand's PHARMAC agrees pricing deal with Sanofi for Arava

04-09-2012

New Zealand's national pharmaceuticals funding agency, PHARMAC, has announced changes to the listings…

Anti-Arthritics/RheumaticsAravaAsia-PacificLeflunomidePharmaceuticalPricingSanofi

Teva launches generic Aprovel in UK

30-08-2012

The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

FDA calls on Genzyme to re-file Lemtrada sBLA

28-08-2012

French drug major Sanofi (Euronext: SAN) revealed yesterday that its US biotech subsidiary has received…

BayerBiotechnologyGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Anti-clotting drugs prasugrel and clopidogrel yield similar results

27-08-2012

The TRILOGY ACS study, the first trial to study patients with acute coronary syndrome who do not undergo…

Bristol-Myers SquibbCardio-vascularDaiichi SankyoEffientEli LillyPharmaceuticalPlavixResearchSanofi

170 to 194 of 311 results

Back to top